文献速递肝病消化道肿瘤与早癌

TGF-β1诱导SOX18升高通过转录上调PD-L1和CXCL12促进肝细胞癌进展和转移

TGF-β1-Induced SOX18 Elevation Promotes Hepatocellular Carcinoma Progression and Metastasis Through Transcriptionally Upregulating PD-L1 and CXCL12.
PubMed 文献 · Gastroenterology · 2024-02-27

该研究探讨SOX18在肝细胞癌免疫抑制微环境中的作用。通过小鼠原位同种移植和化学诱导自发模型,发现SOX18过表达促进TAM和Treg浸润、减少细胞毒性T细胞,从而促进HCC进展和转移。机制上TGF-β1通过Smad2/3上调SOX18,SOX18转录激活CXCL12和PD-L1;CXCR4或TGFβR1抑制剂联合抗PD-L1可显著抑制SOX18介导的HCC进展和转移。

要点

  • SOX18过表达促进TAM和Treg浸润、减少细胞毒性T细胞,加速HCC进展转移。
  • TGF-β1通过Smad2/3上调SOX18,SOX18转录激活CXCL12和PD-L1。
  • CXCR4抑制剂或TGFβR1抑制剂联合抗PD-L1可抑制SOX18介导的HCC进展转移。

核心结论

  • SOX18通过转录激活CXCL12和PD-L1促进免疫抑制性TAM和Treg积累,推动HCC进展和转移。
  • CXCR4抑制剂或TGFβR1抑制剂与抗PD-L1联用是抑制HCC进展和转移的潜在联合策略。

研究设计与样本

  • 研究使用小鼠细胞系、腺相关病毒8及肝细胞特异性敲入和敲除小鼠,在原位同种移植和二乙基亚硝胺/四氯化碳诱导自发模型中进行。
  • 通过流式细胞术和免疫荧光评估HCC微环境免疫细胞组成。

主要发现

  • SOX18过表达促进TAM和Treg浸润、减少细胞毒性T细胞,促进HCC进展和转移。
  • TGF-β1通过激活Smad2/3复合物上调SOX18表达。
  • SOX18转录激活CXCL12和PD-L1以诱导免疫抑制微环境。
  • CXCL12敲低显著减弱SOX18诱导的TAM和Treg积累及HCC播散。
  • 拮抗CXCR4或在TAM/Treg中选择性敲除CXCR4可消除SOX18介导的效应。

关键数值与推荐

  • TGFβR1抑制剂Vactosertib或CXCR4抑制剂AMD3100联合抗PD-L1可显著抑制SOX18介导的HCC进展和转移。

临床怎么用

  • 靶向SOX18-CXCL12/CXCR4轴或TGF-β1-Smad2/3通路联合抗PD-L1可能为HCC免疫治疗提供新策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Hepatocellular carcinoma (HCC) is characterized by an immune-suppressive microenvironment, which contributes to tumor progression, metastasis, and immunotherapy resistance. Identification of HCC-intrinsic factors regulating the immunosuppressive microenvironment is urgently needed. Here, we aimed to elucidate the role of SYR-Related High-Mobility Group Box 18 (SOX18) in inducing immunosuppression and to validate novel combination strategies for SOX18-mediated HCC progression and metastasis. METHODS: The role of SOX18 in HCC was investigated in orthotopic allografts and diethylinitrosamine/carbon tetrachloride-induced spontaneous models by using murine cell lines, adeno-associated virus 8, and hepatocyte-specific knockin and knockout mice. The immune cellular composition in the HCC microenvironment was evaluated by flow cytometry and immunofluorescence. RESULTS: SOX18 overexpression promoted the infiltration of tumor-associated macrophages (TAMs) and regulatory T cells (Tregs) while diminishing cytotoxic T cells to facilitate HCC progression and metastasis in cell-derived allografts and chemically induced HCC models. Mechanistically, transforming growth factor-beta 1 (TGF-β1) upregulated SOX18 expression by activating the Smad2/3 complex. SOX18 transactivated chemokine (C-X-C motif) ligand 12 (CXCL12) and programmed death ligand 1 (PD-L1) to induce the immunosuppressive microenvironment. CXCL12 knockdown significantly attenuated SOX18-induced TAMs and Tregs accumulation and HCC dissemination. Antagonism of chemokine receptor 4 (CXCR4), the cognate receptor of CXCL12, or selective knockout of CXCR4 in TAMs or Tregs likewise abolished SOX18-mediated effects. TGFβR1 inhibitor Vactosertib or CXCR4 inhibitor AMD3100 in combination with anti-PD-L1 dramatically inhibited SOX18-mediated HCC progression and metastasis. CONCLUSIONS: SOX18 promoted the accumulation of immunosuppressive TAMs and Tregs in the microenvironment by transactivating CXCL12 and PD-L1. CXCR4 inhibitor or TGFβR1 inhibitor in synergy with anti-PD-L1 represented a promising combination strategy to suppress HCC progression and metastasis.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Chen J, Feng W, Sun M, et al. TGF-β1-Induced SOX18 Elevation Promotes Hepatocellular Carcinoma Progression and Metastasis Through Transcriptionally Upregulating PD-L1 and CXCL12. Gastroenterology. 2024. PMID: 38417530. doi:10.1053/j.gastro.2024.02.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。